RemSleep Holdings (RMSL) Other Accumulated Expenses (2022)

RemSleep Holdings (RMSL) reported Other Accumulated Expenses of $4740.0 for Q4 2022, down 48.64% on a QoQ basis from $9229.0 in Q2 2022.

RemSleep Holdings (RMSL) Other Accumulated Expenses (2022) Analysis & Trends

RemSleep Holdings has disclosed Other Accumulated Expenses across 1 years of filings, most recently posting $4740.0 for Q4 2022.

On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $4740.0 in Q4 2022; TTM through Dec 2022 was $4740.0, a N/A change from a year earlier, with the FY2022 full-year figure at $4740.0, changed N/A from the prior year.
Other Accumulated Expenses for Q4 2022 stood at $4740.0, down from $9229.0 in the prior quarter.
The five-year high for Other Accumulated Expenses was $9229.0 in Q2 2022, with the low at $4740.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	RemSleep Holdings	-	-	-

Download Data

Date	Value
Dec 31, 2022	4,740.00
Jun 30, 2022	9,229.00